MICROBOT MEDICAL INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure.

On November 18, 2022, Microbot Medical Inc. (the "Company") issued a press release announcing that in a continuation of its efforts to create barriers and expand its global intellectual property portfolio for the LIBERTY® Robotic System, the Company was issued a design patent allowance by the US Patent & Trademark Office (USPTO), covering the LIBERTY Robotic System's remote controller unique interface design.

The press release, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K, is incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including Exhibit 99.1).

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits



Exhibit
Number    Description

99.1        Press Release dated November 18, 2022
104       Cover Page Interactive Data File (embedded within the Inline XBRL
          document)

© Edgar Online, source Glimpses